GSK

News

GSK's chairman Sir Philip Hampton steps down

GlaxoSmithKline is searching for a new chairman after Sir Philip Hampton announced he is to step down in the wake of the company’s split into two businesses.

News

GSK enters PARP space with TESARO acquisition

GSK has announced that it will acquire US-based oncology specialist TESARO for $5.1 billion, gaining access to its PARP inhibitor Zejula (niraparib).

Partner Content

Partner Content

GSK and Sanofi to Present the Opening Keynote Sessions

Cold Chain Distribution Conference

News

Tafenoquine - single shot malaria cure endorsed by the FDA a...

The US Food and Drugs Administration Advisory Committee has endorsed tafenoquine, a single-dose drug from the GSK pipeline that targets one of the most frequent and widely distributed malar

News

GSK collaborates on AI-driven drug design with Cloud Pharmac...

GlaxoSmithKline (GSK) is set to apply artificial intelligence (AI) technology to improve its drug discovery efforts through a collaboration with Cloud Pharmaceuticals.

News